Ping Chen
- Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism 11
- Cancer-related molecular mechanisms research 10
- MicroRNA in disease regulation 7
- Molecular Biology top 5%
- Ubiquitin and proteasome pathways 18
- RNA modifications and cancer 13
- Oncology top 5%
- Cancer-related Molecular Pathways 12
- Cell Biology top 5%
-
- Autophagy in Disease and Therapy 9
-
- Photodynamic Therapy Research Studies 8
- Co-authors
- Tao HuSimon BergqvistZiming DongJames RegisterPatrick M. O’ConnorChunyan ZhouZhuqing JiaKangtao Ma
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Ping Chen
123 papers receiving 3.3k citations
Hit Papers
Peers
Comparison fields: 5 of 123
- Cancer Research 728
- Molecular Biology 2.1k
- Oncology 838
- Cell Biology 298
- Pathology and Forensic Medicine 228
Countries citing papers authored by Ping Chen
This map shows the geographic impact of Ping Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ping Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ping Chen more than expected).
Fields of papers citing papers by Ping Chen
This network shows the impact of papers produced by Ping Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ping Chen. The network helps show where Ping Chen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ping Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 6 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 2 | |
| 7 | 2022 | 28 | |
| 8 | 2020 | 3 | |
| 9 | 2020 | 37 | |
| 10 | Expression of hsa_circ_PVT1 in human hepatocellular carcinoma and its clinical significance | 2018 | 1 |
| 11 | 2018 | 19 | |
| 12 | 2018 | 22 | |
| 13 | Spectrum and Degree of CDK Drug Interactions Predicts Clinical Performancebreakdown → | 2016 | 307 |
| 14 | 2014 | 1 | |
| 15 | The nutrition of fatty acid and amino acid analysis of four genealogies Pseudosciaena crocea (Richardson). | 2009 | 3 |
| 16 | 2008 | 171 | |
| 17 | Tumor suppression activity of ginsenoside Rg_(3) combined with TRAIL gene on human colon cancer cell line HCE8693 | 2004 | 1 |
| 18 | Studies on Photodynamic Effects of CPD_1 on HL-60 Cells in Vitro | 2002 | 1 |
| 19 | Studies on Fluorescence Emission Properties and Quantum Yield of Singlet Oxygen Photosensitized by Chlorin Photosensitizers | 2002 | 3 |
| 20 | 1995 | 65 |
About Ping Chen
Ping Chen is a scholar working on Cancer Research, Molecular Biology, Oncology, Geriatrics and Gerontology and Physiology, having authored 125 papers that have together received 3.3k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (18 papers), RNA modifications and cancer (13 papers), Cancer-related Molecular Pathways (12 papers), Cancer, Hypoxia, and Metabolism (11 papers), Cancer-related molecular mechanisms research (10 papers), Autophagy in Disease and Therapy (9 papers), Photodynamic Therapy Research Studies (8 papers) and MicroRNA in disease regulation (7 papers). The work is most often cited by research in Cancer Research (728 citations), Molecular Biology (2.1k citations), Oncology (838 citations), Cell Biology (298 citations) and Pathology and Forensic Medicine (228 citations). Ping Chen has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Tao Hu, Simon Bergqvist, Ziming Dong, James Register, Patrick M. O’Connor, Chunyan Zhou, Zhuqing Jia, Kangtao Ma, Stephen A. Margosiak and Chen‐Chen Kan. Their work appears in journals such as Oncotarget, Cell Death and Disease, APOPTOSIS, Anti-Cancer Drugs and Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.